Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis shows lower postoperative blood glucose with GLP-1 receptor agonists in bypass surgery, indicating improved perioperative control.
Aim: To determine if glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can benefit patients receiving coronary artery bypass graft (CABG), GLP-1 RAs administration alongside standard insulin was compared with perioperative insulin alone. Materials & methods: All articles from Pubmed and Scopus databases that compared GLP-1 RA administration to insulin alone during CABG were included for meta-analysis. Short-term postoperative outcomes were analyzed between groups. Results: Average postoperative blood glucose levels significantly favored GLP-1 RA with a mean difference of -0.72 (p < 0.001). No other variables were significantly different between GLP-1 RA and insulin alone. Conclusion: GLP-1 RA is a safe option for perioperative care of CABG patients that can potentially improve postoperative outcomes of CABG patients by improving glycemic control and reducing hyperglycemic episodes.
No takes yet. Share an insight, caveat, or question.
Watkins et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: